(lp0
S'A Look at Generex Biotechnology Corporation  MicroCap Daily - Jan 17, 2016 Generex Biotechnology Corporation  has continued to move lower in recent months continuing a trend that has lasted for years.'
p1
aS"Here's What Matters Right Now For Generex Biotechnology Corporation  Insider Financial - Feb 24, 2017 Generex Biotechnology Corporation  rocketed from $0.004 a share to $0.015 between January 20 and January 25, as the company announced it had signed an LOI to acquire a controlling interest in an entity called Emmaus Life Sciences,&nbsp;..."
p2
aS'Deconstructing The Generex Biotechnology Corporation  Pivot Insider Financial - Feb 1, 2017 Between January 20 and January 25, Generex Biotechnology Corporation  ran up from around $0.0045 a share, to $0.012 a share - a more than 166% gain.'
p3
aS'Emmaus Life Sciences, Inc. Enters into Collaborative Agreement with Generex ... PR Newswire  - Jan 24, 2017 TORRANCE, Calif., Jan. 24, 2017 /PRNewswire/ -- Emmaus announced today that it has entered into a letter of intent  to establish a collaborative agreement with Generex Biotechnology Corporation . Emmaus will sell&nbsp;...'
p4
aS'A Waking Bull: Generex Biotechnology Corporation  MicroCap Daily - Apr 21, 2015 Generex Biotechnology Corporation  has seen a recent jump in volume as the stock moves over the $0.02 mark. The stock has been upward bound since hitting an all-time low of $0.0105 in January.'
p5
aS'Generex Biotechnology Corporation  Moves on Recent Developments The Oracle Dispatch - Jan 30, 2017 Generex Biotechnology Corporation  is a micro-cap biotech name that has recently started to rip higher out of sub-penny territory and into the light of day.'
p6
aS'Spotlight on Generex Biotechnology Corporation  MicroCap Daily - Nov 15, 2015 Generex Biotechnology Corporation  is one penny stock that has got Investors attention as it continues to trade moderate volume just below the $0.01 mark.'
p7
aS'Generex Biotechnology Corporation  Pushes Higher on New Catalysts The Oracle Dispatch - Feb 22, 2017 Generex Biotechnology Corporation  is a micro-cap biotech player that has been on the rise of late despite an avalanche of growing debt and no clear route to near term monetization.'
p8
aS'GENEREX BIOTECHNOLOGY CORPORATION  Files An 8-K Material ... Market Exclusive - Mar 17, 2017 Generex Biotechnology Corporation is a development-stage company. The Company is engaged primarily in the research and development of drug delivery systems and technologies.'
p9
aS'Generex Biotechnology Corp. MarketWatch - Mar 27, 2017 Generex Biotechnology Corp. OTC: GNBTD. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p10
a.